| Desiree Lariosa Catalan, DO | |
|
1000 Montauk Hwy, West Islip, NY 11795-4927 | |
| (631) 376-4163 | |
| Not Available |
| Full Name | Desiree Lariosa Catalan |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1000 Montauk Hwy, West Islip, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063670271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 248300 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Desiree Lariosa Catalan, DO 1000 Montauk Hwy, West Islip, NY 11795-4927 Ph: (631) 376-4163 | Desiree Lariosa Catalan, DO 1000 Montauk Hwy, West Islip, NY 11795-4927 Ph: (631) 376-4163 |
News Archive
Two London students, who have invented separate pieces of medical technology that could help revolutionise the lives of people with Parkinson's disease, could soon see their innovative devices available to millions of sufferers after they were shortlisted for a prestigious award.
Highly active antiretroviral therapy (HAART) has been extremely effective at slowing the progression of HIV infection to AIDS as well as extending the lives and improving the quality of life for those with HIV. However, some doctors have been reluctant to prescribe HAART to HIV-infected injection drug users because of concern that they may not fully benefit from the therapy.
MMR Information Systems, Inc. announced today that it is offering a free guide to Personal Health Records ("PHRs") by Dr. Arnold W. Klein, a world-renowned Beverly Hills Dermatologist, through its MyMedicalRecords PHR website www.mymedicalrecords.com. The Company made the announcement in response to the White House declaring the H1N1 "Swine Flu" virus a National Emergency.
Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced dosing of the first patient in its Phase 1b clinical study of APTO-253 in patients with relapsed or refractory hematologic malignancies.
A new inhalable dry powder treatment for lung cancer shows a significant increase in survival rates and is far less invasive than current treatment options, which frequently include radiation and surgery. This research is being presented at the 2010 International Pharmaceutical Federation Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition in New Orleans, La., Nov. 14-18.
› Verified 9 days ago
Dr. Branda Shrivastava, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1000 Montauk Hwy, West Islip, NY 11795 Phone: 631-376-4161 | |
Dr. Kolathu A Mathew, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 720 Montauk Hwy, West Islip, NY 11795 Phone: 631-669-2900 Fax: 631-669-2547 | |
Dr. Eldose Cherian George, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 720 Montauk Hwy, West Islip, NY 11795 Phone: 631-669-2900 | |
Dr. Mary J Bilder, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 239 Higbie Ln, West Islip, NY 11795 Phone: 631-376-6000 Fax: 631-376-6031 | |
Timothy George, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 239 Higbie Ln, West Islip, NY 11795 Phone: 631-376-6000 Fax: 631-376-6031 | |
Reethamma Daniel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1000 Montauk Hwy, West Islip, NY 11795 Phone: 631-376-3000 |